IL10 and systemic lupus erythematosus: Some studies reported that MDSCs ameliorated systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) like symptoms in mouse models by inhibiting Th17 cells differentiation or promoting IL-10+ B cells expansion [9, 10].